Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Markman

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
British Journal of Clinical Pharmacology|March 12, 2022
Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritisJonathan Mauer, Kristin Bullok, Stephen Watt, et al.
Neurology|April 8, 2015
Opioids for chronic noncancer pain: A position paper of the American Academy of NeurologyJeffrey A Katz, Marc A Swerdloff, Steven D Brass, et al.
JMIR Human Factors|November 25, 2025
Turning Patients' Open-Ended Narratives of Chronic Pain Into Quantitative Measures: Natural Language Processing StudyRaquel Norel, Jennifer Gewandter, Zhengwu Zhang, et al.
Journal of Neurology|September 23, 2018
Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trialJohn Markman, Malca Resnick, Scott Greenberg, et al.
Pain|February 13, 2019
SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back painJohn Markman, Jeffrey Gudin, Richard Rauck, et al.
Pain|May 26, 2023
Recommendations for terminology and the identification of neuropathic pain in people with spine-related leg pain. Outcomes from the NeuPSIG working groupAnnina B Schmid, Brigitte Tampin, Ralf Baron, et al.
Pain Medicine (Malden, Mass.)|July 31, 2019
Long-term Safety and Tolerability of NKTR-181 in Patients with Moderate to Severe Chronic Low Back Pain or Chronic Noncancer Pain: A Phase 3 Multicenter, Open-Label, 52-Week Study (SUMMIT-08 LTS)Jeffrey Gudin, Richard Rauck, Charles Argoff, et al.
The Journal of Pain|June 24, 2020
Systematic Review of Research Methods and Reporting Quality of Randomized Clinical Trials of Spinal Cord Stimulation for PainEwan McNicol, McKenzie Ferguson, Kathleen Bungay, et al.
Pain|March 15, 2011
Considerations for extrapolating evidence of acute and chronic pain analgesic efficacyRobert H Dworkin, Dennis C Turk, Ethan Basch, et al.
The Journal of Pain|April 28, 2026
Research recommendations for the HEAL Initiative: a path forward for pain researchRobert W Gereau, Stephani P Sutherland, Tamara Baker, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|March 12, 2022
Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritisJonathan Mauer, Kristin Bullok, Stephen Watt, et al.
Neurology|April 8, 2015
Opioids for chronic noncancer pain: A position paper of the American Academy of NeurologyJeffrey A Katz, Marc A Swerdloff, Steven D Brass, et al.
JMIR Human Factors|November 25, 2025
Turning Patients' Open-Ended Narratives of Chronic Pain Into Quantitative Measures: Natural Language Processing StudyRaquel Norel, Jennifer Gewandter, Zhengwu Zhang, et al.
Journal of Neurology|September 23, 2018
Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trialJohn Markman, Malca Resnick, Scott Greenberg, et al.
Pain|February 13, 2019
SUMMIT-07: a randomized trial of NKTR-181, a new molecular entity, full mu-opioid receptor agonist for chronic low-back painJohn Markman, Jeffrey Gudin, Richard Rauck, et al.
Pain|May 26, 2023
Recommendations for terminology and the identification of neuropathic pain in people with spine-related leg pain. Outcomes from the NeuPSIG working groupAnnina B Schmid, Brigitte Tampin, Ralf Baron, et al.
Pain Medicine (Malden, Mass.)|July 31, 2019
Long-term Safety and Tolerability of NKTR-181 in Patients with Moderate to Severe Chronic Low Back Pain or Chronic Noncancer Pain: A Phase 3 Multicenter, Open-Label, 52-Week Study (SUMMIT-08 LTS)Jeffrey Gudin, Richard Rauck, Charles Argoff, et al.
The Journal of Pain|June 24, 2020
Systematic Review of Research Methods and Reporting Quality of Randomized Clinical Trials of Spinal Cord Stimulation for PainEwan McNicol, McKenzie Ferguson, Kathleen Bungay, et al.
Pain|March 15, 2011
Considerations for extrapolating evidence of acute and chronic pain analgesic efficacyRobert H Dworkin, Dennis C Turk, Ethan Basch, et al.
The Journal of Pain|April 28, 2026
Research recommendations for the HEAL Initiative: a path forward for pain researchRobert W Gereau, Stephani P Sutherland, Tamara Baker, et al.
Pageof 3